Foundation Medicine Inc (FMI)

38.10
1.00 2.60
NASDAQ : Health Care
Prev Close 39.10
Open 39.05
Day Low/High 37.95 / 39.35
52 Wk Low/High 13.34 / 33.31
Volume 169.51K
Avg Volume 216.00K
Exchange NASDAQ
Shares Outstanding 36.02M
Market Cap 1.43B
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cancer Treatment Centers Of America® And Foundation Medicine® Join Forces To Advance Precision Cancer Treatment

Cancer Treatment Centers Of America® And Foundation Medicine® Join Forces To Advance Precision Cancer Treatment

Expanded partnership is aimed at enhancing activities to educate the medical community, patients and caregivers about the latest advancements in genomic testing to improve clinical outcomes in cancer care

FMI INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Foundation Medicine, Inc. And A Lead Plaintiff Deadline Of September 26, 2017

FMI INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Foundation Medicine, Inc. And A Lead Plaintiff Deadline Of September 26, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Foundation Medicine, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Foundation Medicine, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 26, 2017 - FMI

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Foundation Medicine, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 26, 2017 - FMI

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Foundation Medicine, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Foundation Medicine, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 26, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Foundation Medicine, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 26, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Foundation Medicine, Inc.

FMI LOSS NOTICE: Rosen Law Firm Reminds Foundation Medicine, Inc. Investors Of Important Deadline In Class Action - FMI

FMI LOSS NOTICE: Rosen Law Firm Reminds Foundation Medicine, Inc. Investors Of Important Deadline In Class Action - FMI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Foundation Medicine, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Foundation Medicine, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Foundation Medicine, Inc.

The Klein Law Firm announces the commencement of an investigation of Foundation Medicine, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Foundation Medicine, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Foundation Medicine, Inc.

The Klein Law Firm announces the commencement of an investigation of Foundation Medicine, Inc.

EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Foundation Medicine, Inc.

EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Foundation Medicine, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Foundation Medicine, Inc.

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Foundation Medicine, Inc.

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Foundation Medicine, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Foundation Medicine, Inc.

Interesting FMI Put And Call Options For February 2018

Investors in Foundation Medicine Inc saw new options become available this week, for the February 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 197 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Foundation Medicine, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Foundation Medicine, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Foundation Medicine, Inc.

Foundation Medicine Announces 2017 Second Quarter Results And Recent Highlights

Foundation Medicine Announces 2017 Second Quarter Results And Recent Highlights

Foundation Medicine, Inc. (NASDAQ:FMI) today reported financial and operating results for its second quarter ended June 30, 2017.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Foundation Medicine, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Foundation Medicine, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Foundation Medicine, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Foundation Medicine, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Foundation Medicine, Inc. And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Foundation Medicine, Inc.

Foundation Medicine Announces Timing For Second Quarter 2017 Financial Results And Conference Call

Foundation Medicine Announces Timing For Second Quarter 2017 Financial Results And Conference Call

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2017 will be released on Tuesday, August 1, 2017.

ASCO And Foundation Medicine Announce Collaboration To Help Research Sites Identify Potential Participants For The Targeted Agent And Profiling Utilization (TAPUR) Study

The American Society of Clinical Oncology, Inc. (ASCO) and Foundation Medicine (NASDAQ: FMI) today announced entry into an agreement to create efficiencies for research sites participating in ASCO's TAPUR™ Study in...

Foundation Medicine To Identify Patients Eligible For National Cancer Institute's NCI-MATCH (Molecular Analysis For Therapy Choice) Study

Foundation Medicine (NASDAQ: FMI) today announced a collaboration with the National Cancer Institute (NCI) and ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) for their precision medicine cancer trial, NCI-Molecular Analysis...

Noteworthy Monday Option Activity: FMI, DVAX, VICR

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Foundation Medicine Inc , where a total volume of 6,347 contracts has been traded thus far today, a contract volume which is representative of approximately 634,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 245.1% of FMI's average daily trading volume over the past month, of 258,995 shares.

Foundation Medicine To Present At Upcoming Investor Conferences

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the following upcoming investor conferences: Goldman Sachs Annual Healthcare...

Foundation Medicine And Its Collaborators To Present New Data At ASCO 2017 Supporting The Integration Of Comprehensive Genomic Profiling (CGP) In Personalized Clinical Care In Oncology

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that data from its suite of comprehensive genomic profiling (CGP) assays, including FoundationOne ®, FoundationACT ® liquid biopsy, FoundationOne ®...

Foundation Medicine Announces 2017 First Quarter Results And Recent Highlights

Foundation Medicine, Inc. (NASDAQ:FMI) today reported financial and operating results for its first quarter ended March 31, 2017.